$120.65
▼ $-0.12
(-0.10%)
Vol 112K
Mkt Cap
$49.2B
P/E
18.4
ROE
58.2%
Margin
28.2%
Beta
0.95
Div Yield
1.64%
52W
$113–$172
Wall Street Consensus
25 analysts · Apr 20266
Strong Buy
9
Buy
10
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
LLY
Eli Lilly and Co
P/E 43.0
$887.6B
JNJ
Johnson & Johnson
P/E 21.4
$574.4B
MRK
Merck & Co Inc
P/E 16.4
$300.2B
PFE
Pfizer Inc
P/E 19.7
$153.1B
BMY
Bristol-Myers Squibb Co
P/E 17.0
$119.7B
RPRX
Royalty Pharma PLC
P/E 29.2
$22.3B
VTRS
Viatris Inc
$14.3B
ELAN
Elanco Animal Health Inc
$11.5B
AXSM
Axsome Therapeutics Inc
$9.2B
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $1.42 | $1.48 | +$0.06 |
| Sep 2025 | $1.64 | $1.70 | +$0.06 |
| Jun 2025 | $1.63 | $1.76 | +$0.13 |
| Mar 2025 | $1.41 | $1.48 | +$0.07 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $2.3B | $2.2B | $2.5B | $2.4B | $2.4B |
| Net Income | — | $581.0M | $631.0M | $718.0M | $721.0M | $603.0M |
Key Ratios
ROA (TTM)
18.1%
P/S (TTM)
5.20
P/B
16.6
EPS (TTM)
$6.02
CF/Share
$5.96
Rev Growth 3Y
+5.4%
52W High
$172.23
52W Low
$113.29
$113.29
52-Week Range
$172.23
Financial Health
Free Cash Flow
$732.0M
Net Debt
$6.9B
Cash
$2.3B
Total Debt
$9.2B
As of Dec 31, 2025
How does ZTS compare to Pharmaceuticals peers?
Peer group: Peers · Pharmaceuticals (Peers) · 10 companies
ZTS valuation vs Pharmaceuticals peers
P/E ratio
18.4
▼
7%
below
peers
(19.7)
vs Peers
vs Industry
Undervalued
P/S ratio
5.2
▲
6%
above
peers
(4.9)
vs Peers
vs Industry
Fair value
P/B ratio
16.7
▲
205%
above
peers
(5.5)
vs Peers
vs Industry
Overvalued
Div yield
1.6%
▼
35%
below
peers
(2.5%)
vs Peers
vs Industry
Low yield
ZTS profitability vs Pharmaceuticals peers
ROE
58.2%
▲
157%
above
peers
(22.7%)
vs Peers
vs Industry
Top tier
Net margin
28.2%
▲
32%
above
peers
(21.4%)
vs Peers
vs Industry
Below avg
Gross margin
71.9%
▼
1%
below
peers
(72.6%)
vs Peers
vs Industry
Weak
ROA
18.1%
▲
209%
above
peers
(5.9%)
vs Peers
vs Industry
Top tier
ZTS financial health vs Pharmaceuticals peers
D/E ratio
—
▼
0%
below
peers
(139.5)
vs Peers
vs Industry
In line
Current ratio
3.0
▲
95%
above
peers
(1.6)
vs Peers
vs Industry
Strong liquidity
Beta
1.0
▲
126%
above
peers
(0.4)
vs Peers
vs Industry
More volatile
ZTS fundamentals radar
ZTS
Peer median
Industry
ZTS profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
ZTS vs peers: key metrics
Dividends
$2.03
/ year
Jan 20, 2026
$0.5300
Oct 31, 2025
$0.5000
Jul 18, 2025
$0.5000
Apr 21, 2025
$0.5000
Jan 21, 2025
$0.5000
Oct 31, 2024
$0.4320
Jul 18, 2024
$0.4320
Apr 18, 2024
$0.4320